Healthcare / Medical Care FacilitiesThailand
$2.54
-0.06 (-2.31%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $52.0M · quality 44.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$559M
P/E
25.4x
↑EV/EBITDA
5.5x
↓ROE
3.9%
↑Gross Margin
41.7%
↓Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.6%
FCF CAGR
—
FCF margin
14.7%
FCF / Net income
2.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $353.0M · net income $22.4M · FCF $52.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $353.0M | $353.0M | $371.8M | $354.6M | $275.9M |
| Net Income | $22.4M | $22.4M | $73.5M | $77.5M | $65.7M |
| EBITDA | $84.1M | $84.1M | $114.3M | $116.9M | $96.8M |
| EPS | — | — | 0.33 | 0.43 | 0.30 |
| Gross Margin | 41.7% | 41.7% | 48.0% | 48.6% | 47.1% |
| Operating Margin | 9.8% | 9.8% | 25.3% | 28.9% | 29.8% |
| Net Margin | 6.3% | 6.3% | 19.8% | 21.9% | 23.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.05 | 0.04 | 1.36 |
| Current Ratio | 3.14 | 3.14 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $52.0M | $52.0M | $-104.0M | $86.9M | $-153.4M |
| Returns | |||||
| ROE | 3.9% | 3.9% | 12.6% | 13.8% | 42.5% |
| Valuation | |||||
| P/E | 25.40 | 25.40 | 21.52 | 24.42 | — |
| EV/EBITDA | 5.45 | 5.45 | 12.56 | 13.63 | — |
| P/B | 0.98 | 0.98 | 2.68 | 3.35 | — |
| Growth & Yield | |||||
| Revenue Growth | -5.0% | -5.0% | 4.8% | 28.5% | — |
| EPS Growth | — | — | -23.3% | 44.0% | — |
| Dividend Yield | 5.0% | 5.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.2%
Start / end P/E
n/dx → n/dx
EPS bridge
0.33 → n/d
Residual
-41.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.